Endpoints at #JPM24 | Primed to unlock biopharma's next dealmaking wave
Monday, June 3, 2024
7:00 AM -  12:00 PM PT 
Marriott Marquis
SAN DIEGO MARINA

Endpoints is back at BIO. The industry is descending on sunny San Diego with a sense of renewed optimism after a rough year. Just a few steps away from the convention center, we’re kicking off BIO with our exclusive networking breakfast lineup Monday morning. Join us for conversations about the ways US/China policy impacts biotech, gene therapy commercialization and lessons learned from last year — and find out who experts think is winning biotech's comeback.

Choose your pass

SPONSORED BY

Agenda-at-a-glance

Endpoints reporters and editors interview leading experts in biotech and beyond. More to come.

See Full agenda
  • 7:00 - 8:15am PT
    Networking breakfast
  • 8:15 - 8:20am PT
    Welcome remarks
  • 8:20 - 9:45am PT
    Series of interviews + panels
  • 9:45 - 10:00am PT
    Networking break
  • 10:00 - 11:45am PT
    Series of interviews + panels

Choose your pass:

Get tickets for one or more — your in-person experience includes a networking breakfast before the sessions begin.

Want to bring the team or entertain clients? Get a table and showcase your company logo.

Can’t make it? Join our livestream at no charge.

Executive pass

  • Access to all in-person sessions on Monday AM
  • Networking, coffee + breakfast
$275
get your ticket

vip table

  • Access to all in-person sessions + networking breakfast
  • Tickets for 8 + company logo on table
$2000
RESERVE a TABLE

virtual Pass

  • Can’t make it to the event in-person? Tune in to the livestream
  • Access to all sessions on June 3
Free
watch online

Speakers

From our very own journalists to industry pioneers to thought leaders, all of our speakers bring unique expertise and insight to the stage.

Lynn Seely
President & CEO
Lyell Immunopharma
Lynn Seely
Andrew Lam
Managing Director, Head of Biotech Private Equity
Ally Bridge Group
Andrew Lam
Kurt von Emster
Managing Partner, Head of Life Sciences
Abingworth
Kurt von Emster
Jami Rubin
Chief Financial Officer
Boundless Bio
Jami Rubin
Benjamin Oakes
Co-Founder, President, and CEO
Scribe Therapeutics
Benjamin Oakes
Tim Opler
Managing Director
Stifel
Tim Opler
Nick Shipley
Former Chief Advocacy Officer, BIO
Biopharma Consultant, Former BIO and PhRMA Senior Executive
Nick Shipley
Helen Chen
Global Sector Co-Head, Healthcare and Life Sciences | Greater China Managing Partner
L.E.K. Consulting
Helen Chen
Aviv Regev
Executive VP, Head of Genentech Research & Early Development (gRED)
Genentech
Aviv Regev
Tom Kilma
Chief Operating and Commercial Officer
bluebird bio
Tom Kilma

Moderators

Andrew Dunn
Biopharma Correspondent
Endpoints News
Andrew Dunn
Arsalan Arif
Founder & Publisher
Endpoints News
Arsalan Arif
Drew Armstrong
Executive Editor
Endpoints News
Drew Armstrong
John Carroll
Founder & Editor
Endpoints News
John Carroll
Amber Tong
Senior Editor
Endpoints News
Amber Tong